I'm not in the financial sector, however If I was spruiking this...

I'm not in the financial sector, however If I was spruiking this to my friends which I be careful not to do, I would downplay my realistic view in an attempt to set their expectations at a lower level.
That said, IMO Neuren's value has always been undervalued. Positive news has come and gone for years with little, to none, to negative impacts on valuations. Perhaps having 2591 at early stages of development, they have heightened the risk of failure into the price to an almost negligent level of value, with the outcome of positive results being of significant level, the resultant earnings may not yet be priced in, although promising to date.

IMO only. Can't wait to hear from parents of the children on the positive outcomes once their treatments begin to be administered.

Out of curiosity, does anybody have on hand their recommendation of a retts charity to donate some profits to? When it comes time to sell that is which may be some time yet...